paperBiotech

Multimodal biomarkers in idiopathic sudden sensorineural hearing loss: integrating immune, vascular, and metabolic perspectives for precision medicine

Multimodal biomarkers in idiopathic sudden sensorineural hearing loss: integrating immune, vascular, and metabolic perspectives for precision medicine

publishedDate Venue Frontiers in Immunology

Source-permitted summary

Multimodal biomarkers in idiopathic sudden sensorineural hearing loss: integrating immune, vascular, and metabolic perspectives for precision medicine

SourceFrontiers Media SA

Verified by AISci

Public source attached

Source status for this paper in the current AISci reviewed snapshot.

Primary source
Frontiers Media SA
Correction status
none
Evidence coverage
1 sources / 1 publishers
Last metadata check
Jul 19, 2026
Open primary source

AI Reading Notes

Core signal

Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.

Core signal
Multimodal biomarkers in idiopathic sudden sensorineural hearing loss: integrating immune, vascular, and metabolic perspectives for precision medicine
Field context
Diagnostics and Biomarkers
People and labs
Not stated in the reviewed source.
Why it matters
Recent source-backed research output for AISci Stage A browsing.
Limits to check
AISci rank score does not assess scientific quality or citation impact.

Publication facts

Date
Jul 10, 2026SourceFrontiers Media SA
Venue
Frontiers in ImmunologySourceFrontiers Media SA
Open access
unknownSourceFrontiers Media SA

External IDs

Author order

No reviewed author edge is attached to this output.

Organizations

No source-confirmed author affiliation is attached.

Related events

Topics

Relationship evidence

Timeline

  1. paperMultimodal biomarkers in idiopathic sudden sensorineural hearing loss: integrating immune, vascular, and metabolic perspectives for precision medicine